keyword
https://read.qxmd.com/read/38687939/stem-like-cd8-t-cells-in-stage-i-lung-adenocarcinoma-as-a-prognostic-biomarker-a-preliminary-study
#1
JOURNAL ARTICLE
Jing Sang, Peng Liu, Meixiang Wang, Fengkuo Xu, Ji Ma, Zhigang Wei, Xin Ye
OBJECTIVES: This study aimed to investigate the presence of stem-like CD8 T (CD8 TSL) cells in lung adenocarcinoma (LUAD) and explore their relationships with the clinical outcomes. METHODS: Multiplex immunofluorescence (mIF) was performed to identify CD8 TSL and antigen-presenting cells (APC) in 76 LUAD patients. Differences in the number of CD8 TSL cells based on tumor stage and the spatial relationships between CD8 TSL cells and APC niches were determined. The optimal cutoff value of CD8 TSL cells for predicting survival in patients with stage I LUAD was calculated...
April 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38687931/evolution-of-neoadjuvant-therapy-for-breast-cancer-regimens-over-12-years-and-pathologic-response-rates-according-to-tumor-subtypes-and-clinical-stage-a-single-center-retrospective-study
#2
JOURNAL ARTICLE
Zhedong Li, Yongsheng Wang
BACKGROUND AND PURPOSE: Given the evolution of neoadjuvant therapy (NAT) for breast cancer, this study aimed to analyze trends in NAT regimens over time and patients' pathological responses, tumor stages, and subtypes. MATERIALS AND METHODS: Data were analyzed for 548 patients with cT1-4N0-3M0 breast cancer who received NAT at Shandong Cancer Hospital between 2011 and 2022. The 12-year study period was divided into six 2-year periods termed P1 to P6. RESULTS: From P1 to P6, the proportion of stage II patients treated with NAT increased from 6...
April 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38687603/cervicovaginal-metabolome-and-tumor-characteristics-for-endometrial-cancer-detection-and-risk-stratification
#3
JOURNAL ARTICLE
Georgia M Lorentzen, Pawel Laniewski, Haiyan Cui, Nichole D Mahnert, Jamal Mourad, Matthew P Borst, Lyndsay Willmott, Dana M Chase, Denise J Roe, Melissa M Herbst-Kralovetz
PURPOSE: Endometrial cancer is highly prevalent and lacking non-invasive diagnostic techniques. Diagnosis depends on histological investigation of biopsy samples. Serum biomarkers for endometrial cancer have lacked sensitivity and specificity. The objective of this study was to investigate the cervicovaginal environment to improve understanding of metabolic reprogramming related to endometrial cancer and identify potential biomarker candidates for non-invasive diagnostic and prognostic tests...
April 30, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38687407/relationship-between-her2-low-status-and-efficacy-of-cdk4-6-inhibitors-in-advanced-breast-cancer-a-real-world-study
#4
JOURNAL ARTICLE
T Önder, Ö Ateş, I Öner, C Karaçin
AIMS AND OBJECTIVES: Human epidermal growth factor receptor 2 (HER2)-low breast cancer (BC) is a new entity considered a biologically distinct subtype from HER2-zero BC. However, the importance of HER2 low expression on the activity of cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) remains unclear. METHODS/MATERIALS: We conducted a single-center retrospective study including hormone receptor-positive (HR +) /HER2- metastatic BC (mBC) patients treated with CDK4/6i plus endocrine treatment (ET) as first-line therapy...
April 30, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38686982/atypical-glandular-cells-and-predictive-features-of-malignancy-in-pap-smears-a-retrospective-monocentric-study
#5
JOURNAL ARTICLE
Federica Cianfrini, Antonio d'Amati, Damiano Arciuolo, Antonio Travaglino, Nicoletta D'Alessandris, Giulia Scaglione, Michele Valente, Belen Padial Urtueta, Francesca Addante, Nadine Narducci, Giuseppe Angelico, Alessia Piermattei, Antonino Mulè, Angela Santoro, Esther Diana Rossi, Gian Franco Zannoni
OBJECTIVE: The introduction of cytological screening with the Papanicolau smear significantly reduced cervical cancer mortality. However, Pap smear examination can be challenging, being based on the observer ability to decode different cytological and architectural features. This study aims to evaluate the malignancy rate of AGC (atypical glandular cells) category, investigating the relationships between cytological and histological diagnosis. METHODS: Eighty-nine patients, diagnosed as AGC at cytological evaluation and followed up with biopsy or surgical procedure at Policlinico Gemelli Hospital, Rome, Italy, were included in the study...
April 30, 2024: Cytopathology: Official Journal of the British Society for Clinical Cytology
https://read.qxmd.com/read/38686798/clinical-impact-of-skeletal-muscle-mass-change-during-the-neoadjuvant-chemotherapy-period-in-patients-with-gastric-cancer-an-ancillary-study-of-jcog1002
#6
JOURNAL ARTICLE
Reo Sato, Masanori Tokunaga, Junki Mizusawa, Yuya Sato, Seiji Ito, Daisuke Takahari, Takeshi Sano, Hiroaki Onaya, Takaki Yoshikawa, Narikazu Boku, Masanori Terashima
BACKGROUND: Recent studies have revealed that sarcopenia is associated with postoperative complications and poor prognosis. Although neoadjuvant chemotherapy is a promising treatment for gastric cancer, its toxicity may lead to the loss of skeletal muscle mass. This study investigates the changes in skeletal muscle mass during neoadjuvant chemotherapy and its clinical impact on patients with locally advanced gastric cancer. METHODS: Fifty patients who completed two courses of neoadjuvant chemotherapy followed by surgery were included...
January 2024: World Journal of Surgery
https://read.qxmd.com/read/38686714/-detection-and-significance-of-molecular-markers-in-immunotherapy-and-targeted-therapy-of-colorectal-cancer-in-tibet
#7
JOURNAL ARTICLE
Han-Huan Luo, Bin-Yun Liu, Zhen Huo, BIANbazhaxi, Qian Wang, DUObula, NImazhuoma, Zhen DA, Han Wang, Ping-Ping Guo
Objective To study the expression of SWI/SNF-related,matrix-associated,actin-dependent regulator of chromatin,subfamily A,member 4(SMARCA4)/Brahma-related gene 1,V-raf murine sarcoma viral oncogene homolog B(BRAF),P53,programmed cell death protein-1(PD-1),and programmed death-ligand 1(PD-L1),and changes in the expression of BRAF and neurotrophic tyrosine receptor kinase(NTRK) in the patients with colorectal cancer in Tibet,thereby providing a basis for targeted therapy and immunotherapy for this disease in Tibet...
April 2024: Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
https://read.qxmd.com/read/38686207/the-clinical-value-of-iodine-125-seed-implantation-in-the-treatment-of-iodine-refractory-differentiated-thyroid-carcinoma
#8
JOURNAL ARTICLE
Qin Wan, Liling Tan, Xinlan Tang, Wenjun Wang, Yu Su, Zhen Wu, Mengmeng Ke, Zhijun Chen
OBJECTIVE: To explore the clinical benefits of 125 I seed implantation for iodine-refractory differentiated thyroid cancer (RAIR-DTC). METHODS: A retrospective analysis was conducted on 36 patients with RAIR-DTC who underwent radioactive 125 I seed implantation from January 2015 to February 2022, involving 73 lesions. Prescription dose: 80~120 Gy. All cases were followed up at 1, 3, and 5 months postoperatively to monitor changes in tumor size, serum thyroglobulin (Tg), and serum anti-thyroglobulin antibody levels in thyrotropin-inhibited states, pain scores, and postoperative adverse reactions...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38686198/short-and-long-term-outcomes-after-surgical-treatment-of-5918-patients-with-splenic-flexure-colon-cancer-by-extended-right-colectomy-segmental-colectomy-and-left-colectomy-a-systematic-review-and-meta-analysis
#9
Yu Cao, Mingze He, Kuo Chen, Zheng Liu, Denis I Khlusov, Tatyana V Khorobrykh, Xinren Cao, Polina D Panova, Sergey K Efetov, Airazat M Kazaryan
BACKGROUND: Colorectal cancer is among the most common cancers in the world, and splenic flexure colon cancer accounts for about 2-5% of them. There is still no consensus on the surgical treatment of splenic flexure colon cancer (SFCC), and the extent of surgical resection and lymph node dissection for SFCC is still controversial. AIM: To compare the postoperative and long-term oncologic outcomes of extended right colectomy (ERC), segmental colectomy (SC) and left colectomy (LC) for SFCC...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38685816/the-use-of-pembrolizumab-monotherapy-for-the-management-of-head-and-neck-squamous-cell-carcinoma-hnscc-in-the-uk
#10
JOURNAL ARTICLE
Ifigenia Vasiliadou, Derek Grose, Christina Wilson, Alekh Thapa, Olly Donnelly, Elsa Lee, Isla Leslie, Mahwish Karim, Andrew Hartley, Sarah Partridge, Katharine Medlow, James De Boisanger, Robert Metcalf, Andrew Williamson, Anoop Haridass, David Noble, Karen Mactier, Harriet Walter, Ning Ma, Emma De Winton, Jennifer Cohen, Lindsay Rayner, Konstantinos Geropantas, Petra Jankowska, Jessica Mason, Rafael Moleron, Kirsten Laws, Danny Ulahannan, Chandran Nallathambi, Andriana Michaelidou, Susanna Nallamilli, Sherif Raouf, Kieran Palmer, Maya Bienz, Tracy Karet, Saira Khalique, Claire Paterson, Kevin Harrington, Shreerang Bhide, Anthony Kong
Pembrolizumab has received approval in the UK as first-line monotherapy for recurrent and/or metastatic HNSCC (R/M HNSCC) following the results of the KEYNOTE-048 trial, which demonstrated a longer overall survival (OS) in comparison to the EXTREME chemotherapy regimen in patients with a combined positive score (CPS) ≥1. In this article, we provide retrospective real-world data on the role of pembrolizumab monotherapy as first-line systemic therapy for HNSCC across 18 centers in the UK from March 20, 2020 to May 31, 2021...
April 29, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38683939/the-influence-of-home-versus-clinic-anal-human-papillomavirus-sampling-on-high-resolution-anoscopy-uptake-in-the-prevent-anal-cancer-self-swab-study
#11
RANDOMIZED CONTROLLED TRIAL
Jenna Nitkowski, Timothy J Ridolfi, Sarah J Lundeen, Anna R Giuliano, Elizabeth Y Chiao, Maria E Fernandez, Vanessa Schick, Jennifer S Smith, Bridgett Brzezinski, Alan G Nyitray
Background Anal cancer disproportionately affects sexual and gender minority individuals living with HIV. High-resolution anoscopy (HRA) is an in-clinic procedure to detect precancerous anal lesions and cancer, yet prospective data on factors associated with HRA attendance are lacking. We examined whether anal HPV sampling at home versus in a clinic impacts HRA uptake and assessed HRA acceptability. Methods Sexual and gender minority individuals were randomised to home-based self-sampling or clinical sampling...
April 2024: Sexual Health
https://read.qxmd.com/read/38681865/knowledge-of-non-invasive-biomarkers-of-breast-cancer-risk-factors-and-bse-practices-among-nursing-undergraduates-in-farasan-island-ksa
#12
JOURNAL ARTICLE
Shabihul Fatma Sayed, Hamad G Dailah, Sumathi Nagarajan, Siddig Ibrahim Abdelwahab, Shaived S Hasan Abadi, Nida Akhtar, Gulrana Khuwaja, Wadeah Ali DA Malham
BACKGROUND OF THE STUDY: Mammograms are sometimes met with issues of overdiagnosis and underdiagnosis; therefore, they are less reliable in identifying cancer in women with dense breasts. As a result, it is critical to be aware of other sensitive screening techniques for the early diagnosis of breast cancer. AIM: The ultimate objective of this study was to assess the knowledge of nursing undergraduates regarding non-invasive biomarkers, such as volatile organic compounds in breath, nipple aspirate fluid, sweat, urine, and tears, for the early detection of breast cancer to help improve patient care, determine the risk factors, and encourage practice of breast self-examination...
2024: SAGE Open Nursing
https://read.qxmd.com/read/38680290/treatment-with-nanosomal-paclitaxel-lipid-suspension-versus-conventional-paclitaxel-in-metastatic-breast-cancer-patients-a-multicenter-randomized-comparative-phase-ii-iii-clinical-study
#13
JOURNAL ARTICLE
Chiradoni Thungappa Satheesh, Rakesh Taran, Jitendra Kumar Singh, Shanti Prakash Shrivastav, Nikunj K Vithalani, Kalyan Kusum Mukherjee, Rajnish Vasant Nagarkar, Tanveer Maksud, Ajay Omprakash Mehta, Krishnan Srinivasan, Mummaneni Vikranth, Satish Ramkrishna Sonawane, Ateeq Ahmad, Saifuddin Sheikh, Shoukath M Ali, Ronak Patel, Mahesh Paithankar, Lav Patel, Anil Rajani, Deepak Bunger, Alok Chaturvedi, Imran Ahmad
BACKGROUND: A novel nanosomal paclitaxel lipid suspension (NPLS), free from Cremophor EL (CrEL) and ethanol, was developed to address the solvent-related toxicities associated with conventional paclitaxel formulation. OBJECTIVE: To evaluate the efficacy and safety of NPLS versus CrEL-based paclitaxel (conventional paclitaxel) in patients with metastatic breast cancer (MBC). DESIGN: A prospective, open-label, randomized, multiple-dose, parallel, phase II/III study...
2024: Therapeutic Advances in Medical Oncology
https://read.qxmd.com/read/38680012/functional-outcomes-following-anterior-resection-for-colorectal-cancer-a-needs-assessment-and-proposal-of-a-nurse-led-remote-management-algorithm
#14
JOURNAL ARTICLE
Thuy-My Nguyen, Luke Traeger, Bronwyn Overall, Tarik Sammour, Michelle Thomas
AIM: With the rise of structured, remote follow-up of colorectal cancers, there is the potential risk of underdiagnosing and undermanaging low anterior resection syndrome (LARS). This cohort study aims to determine the rate of LARS and its patterns of care, with the aim of generating a risk-stratified management algorithm that can be employed for nurse-led follow-up. METHOD: Patients who underwent elective anterior resection for the management of colorectal cancer between 1 January 2017 and 31 December 2021 were sent quality-of-life questionnaires (EORTC-QLQ-CR29 and LARS score) and surveyed for LARS symptoms and management utilized...
April 28, 2024: ANZ Journal of Surgery
https://read.qxmd.com/read/38680002/evaluation-of-circular-rna-smarca5-as-a-novel-biomarker-for-hepatocellular-carcinoma
#15
JOURNAL ARTICLE
Hanan M Bedair, Elaf A El-Banna, Elhamy A Ahmed, Mostafa G Elhelbawy, Ahmed Abdelfattah, Fatma A Khalaf, Mohamed Abdel-Samiee, Amal El Sharnoby
BACKGROUND: Hepatocellular carcinoma (HCC) is the fourth most prevalent type of cancer in Egypt and the sixth globally. Most patients with HCC are typically diagnosed during the advanced stages of the disease due to the absence of biomarkers for early detection. Consequently, these patients miss the optimal timeframe for receiving therapy. OBJECTIVE: we aimed to assess the circular RNA SMARCA5 level and SMARCA5 mRNA gene expression as a potential biomarker for early detection of HCC...
April 1, 2024: Asian Pacific Journal of Cancer Prevention: APJCP
https://read.qxmd.com/read/38679976/outcomes-of-induction-chemotherapy-followed-by-chemoradiotherapy-versus-chemoradiotherapy-alone-in-esophageal-squamous-cell-carcinoma-induction-chemotherapy-in-esophageal-squamous-cell-carcinoma
#16
MULTICENTER STUDY
Saeed Hosseini Toudeshki, Maryam Garousi, Amir Mohammad Arefpour, Pedram Fadavi, Ali Basi, Ahmad Foroughi, Seyed Alireza Javadinia
BACKGROUND: There is still no definite conclusion regarding the effect of Induction Chemotherapy (IC) combined with concurrent Chemoradiotherapy (CRT). Thus this study was aimed to assess outcomes of IC followed By CRT versus CRT alone in Esophageal Squamous Cell Carcinoma (ESCC). METHODS: This multicenter retrospective study performed on 105 patients who underwent CRT and 73 patients who underwent IC+CRT, between January 2016 and December 2018. The primary endpoints were OS (from the date of treatment to the date of death or 3- years follow-Up)...
April 1, 2024: Asian Pacific Journal of Cancer Prevention: APJCP
https://read.qxmd.com/read/38679975/long-noncoding-rna-hotair-upregulation-is-associated-with-poor-breast-cancer-outcome-a-systematic-review-and-meta-analysis
#17
JOURNAL ARTICLE
Suwardjo Suwardjo, Kavi Gilang Permana, Teguh Aryandono, Didik Setyo Heriyanto, Sumadi Lukman Anwar
BACKGROUND: Breast cancer is the most frequent cancer among women worldwide with significant disproportionate mortality rates in developing countries. Although clinical management of breast cancer has been immensely improved, refinement in the prognostic and recurrent markers is still needed. Long non-coding RNAs (lncRNA) HOTAIR has recently been associated with poor outcome and is potentially used as a prognostic marker in breast cancer. METHODS: We comprehensively reviewed studies evaluating lncRNA HOTAIR in association with overall and disease-free survivals in breast cancers...
April 1, 2024: Asian Pacific Journal of Cancer Prevention: APJCP
https://read.qxmd.com/read/38679017/the-hammersmith-score-optimises-patient-selection-and-predicts-for-overall-survival-in-early-phase-cancer-trial-participants-independent-of-tumour-burden
#18
James Alexander Korolewicz, Bernhard Scheiner, Claudia A M Fulgenzi, Antonio D'Alessio, Alessio Cortellini, Chynna Pascual, Aman Mehan, Sarah Partridge, Dorothy M Gujral, Waleed Mohammed, Oreoluwa Mohammed, Aneta Grzesiak, Lauren Booker, Susan Cleator, Tzveta Pokrovska, Waqar Saleem, James Rackie, Yasmine Needham, Jonathan Krell, Iain McNeish, Laura Tookman, Won-Ho Edward Park, Muzamil Asif, Joanne S Evans, David J Pinato
INTRODUCTION: As tumour response rates are increasingly demonstrated in early-phase cancer trials (EPCT), optimal patient selection and accurate prognostication is paramount. Hammersmith Score (HS), a simple prognostic index derived on routine biochemical measures (Albumin <35g/L, Lactate Dehydrogenase (LDH) >450 IU/L, Sodium <135mmol/L) is a validated predictor of response and survival in EPCT participants. HS has not been validated in the cancer immunotherapy era...
April 27, 2024: Chemotherapy
https://read.qxmd.com/read/38678796/meta-analysis-of-the-efficacy-of-neoadjuvant-chemotherapy-for-locally-advanced-cervical-cancer
#19
REVIEW
Daying Wang, Xiuli Fang
BACKGROUND: Neither improvements in surgical techniques and methods nor advances in radiotherapy equipment and techniques have significantly improved cervical cancer survival rates for quite some time. AIM: By comparing the effectiveness of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer, this study aimed to explore effective treatment methods for locally advanced cervical cancer, and provide a theoretical basis to guide clinical practice...
April 18, 2024: European Journal of Obstetrics, Gynecology, and Reproductive Biology
https://read.qxmd.com/read/38678327/-quantitative-her2-mrna-assay-in-breast-cancer-with-her2-immunohistochemistry-0
#20
JOURNAL ARTICLE
M C Sun, S F Wu, Y M Cai, Y Y Liu, K M Li, D C Zhao, X Zeng
Objective: To investigate HER2 mRNA expression in breast cancer with HER2 immunohistochemistry (IHC) 0 and to analyze the feasibility of distinguishing between the tumor with HER2 μltra-low expression and the one without expression of HER2 (no staining by IHC) by HER2 mRNA level preliminarily. Methods: HER2 mRNA was analyzed by reverse transcription digital PCR in 41 cases of formalin-fixed paraffin-embedded surgical tissue samples of invasive breast cancer obtained between January 2020 and March 2023 at Peking Union Medical College Hospital...
May 8, 2024: Zhonghua Bing Li Xue za Zhi Chinese Journal of Pathology
keyword
keyword
118387
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.